WKN: | A0LBFE |
ISIN: | DE000A0LBFE4 |
Land: | Deutschland |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Medizintechnik |
Weshalb die MeVis Medical Solutions-Aktie
ein C-Rating hat,
erfahren Sie im Performance-Check
vom 26. August 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2013 | 8,41 | 20,11 | 139,06% |
2 | 2012 | 3,71 | 8,41 | 126,68% |
3 | 2016 | 24,01 | 37,75 | 57,23% |
4 | 2015 | 18,16 | 24,01 | 32,21% |
5 | 2022 | 30,80 | 35,00 | 13,64% |
6 | 2017 | 37,75 | 39,32 | 4,17% |
7 | 2020 | 30,60 | 31,80 | 3,92% |
8 | 2025 | 24,60 | 24,60 | 0,00% |
9 | 2024 | 25,00 | 24,60 | -1,60% |
10 | 2021 | 31,80 | 30,80 | -3,14% |
11 | 2019 | 33,20 | 30,60 | -7,83% |
12 | 2014 | 20,11 | 18,16 | -9,67% |
13 | 2008 | 48,00 | 40,54 | -15,54% |
14 | 2018 | 39,32 | 33,20 | -15,57% |
15 | 2023 | 35,00 | 25,00 | -28,57% |
16 | 2009 | 40,54 | 23,79 | -41,32% |
17 | 2010 | 23,79 | 12,84 | -46,03% |
18 | 2011 | 12,84 | 3,71 | -71,11% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2011 | 12,84 | 3,71 | -71,11% |
2 | 2010 | 23,79 | 12,84 | -46,03% |
3 | 2009 | 40,54 | 23,79 | -41,32% |
4 | 2023 | 35,00 | 25,00 | -28,57% |
5 | 2018 | 39,32 | 33,20 | -15,57% |
6 | 2008 | 48,00 | 40,54 | -15,54% |
7 | 2014 | 20,11 | 18,16 | -9,67% |
8 | 2019 | 33,20 | 30,60 | -7,83% |
9 | 2021 | 31,80 | 30,80 | -3,14% |
10 | 2024 | 25,00 | 24,60 | -1,60% |
11 | 2025 | 24,60 | 24,60 | 0,00% |
12 | 2020 | 30,60 | 31,80 | 3,92% |
13 | 2017 | 37,75 | 39,32 | 4,17% |
14 | 2022 | 30,80 | 35,00 | 13,64% |
15 | 2015 | 18,16 | 24,01 | 32,21% |
16 | 2016 | 24,01 | 37,75 | 57,23% |
17 | 2012 | 3,71 | 8,41 | 126,68% |
18 | 2013 | 8,41 | 20,11 | 139,06% |